Amanote Research
Register
Sign In
A Randomised, Double Masked, Multicentre Clinical Trial Comparing Bimatoprost and Timolol for the Treatment of Glaucoma and Ocular Hypertension
British Journal of Ophthalmology
- United Kingdom
doi 10.1136/bjo.87.1.57
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Date
January 1, 2003
Authors
S M Whitcup
Publisher
BMJ
Related search
Correction: Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial. A Multicentre, Randomised Controlled Trial: Design and Methodology
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Prostaglandin F2-Alpha Eye Drops (Bimatoprost) in Graves’ Orbitopathy: A Randomised Controlled Double Masked Crossover Trial (Bima Trial)
Thyroid
Medicine
Endocrinology
Metabolism
Diabetes
Fixed-Combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil☆
Clinical Therapeutics
Pharmacology
A Prospective, Randomised, Placebo-Controlled, Double-Masked, Three-Armed, Multicentre Phase II/III Trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma – The STRONG Study: Study Protocol for a Randomised Controlled Trial
Trials
Medicine
Pharmacology
Managing Refractory Glaucoma With a Fixed Combination of Bimatoprost (0.03%) and Timolol (0.5%)
Clinical Ophthalmology
Ophthalmology
Treatment of Open-Angle Glaucoma and Ocular Hypertension With Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
Advances in Therapy
Medicine
Pharmacology
Multicentre Randomised Trial Comparing High and Low Dose Surfactant Regimens for the Treatment of Respiratory Distress Syndrome (The Curosurf 4 Trial).
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Treatment of Ocular Hypertension and Glaucoma With Dopamine Antagonists
Ophthalmic Research
Medicine
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
A Study of the Effects of Topical Timolol 0.5% and Bimatoprost 0.03% on the Ocular Surface
Journal of Evidence Based Medicine and Healthcare
